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Dear Sir,
We concur with observations made by Dr. Ahmed 
in his letter "Anaerobic storage of red blood cells: 
the need for caution regarding donor red cells with 
sickle cell trait"1 about the potential unsuitability of 
anaerobic conditions for the storage of sickle cell 
trait (SCT) blood. Blood containing HbAS is well 
known to clog up leucoreduction Þ lters and to enable 
unacceptable levels of leucocytes to escape during the 
Þ ltering process2.  At sufÞ ciently low pO
2
, pH and 
high mean corpuscular haemoglobin concentration, 
HbAS in red blood cells (RBC) of SCT carriers 
polymerises. Although SCT is considered benign, 
symptoms and pathology suggesting occurrences 
of serious sickling events have been reported in 
numerous cases involving healthy SCT carriers placed 
under extremely demanding anoxic conditions3. 
Polymerisation of HbAS is well underway at a pO
2
 
below 35 Torr for RBC with an HbS content of 40% 
or less, reducing RBC deformability and resulting 
in the well-described obstruction of leucoreduction 
Þ lters2. In order to obtain signiÞ cant anti-oxidative 
and metabolic beneÞ ts, we target anaerobic red blood 
cells to have less than 3% haemoglobin oxygen 
saturation (%SO
2
) before placing units in storage, 
and then maintain this low SO
2
 state throughout the 
storage period4.  The pO
2
 required to achieve an SO
2
 
below 3% is less than 5 Torr at 4 °C, and under such 
a low pO
2
, HbAS would polymerise. Even if it was 
permissible, inclusion of anti-sickling agents would 
be insufÞ cient to prevent HbAS polymerisation, and 
storing RBC under a highly sickled state is known 
to be unacceptable because of prolonged mechanical 
stress to the cells and resulting haemolysis. If 
successful collection and storage of SCT blood is 
speciÞ cally desired, a test to exclude units with HbAS 
will be necessary to avoid subjecting these collected 
RBC to the anaerobic treatment. Further investigation 
will be required to determine the feasibility of storing 
SCT blood with a low HbS content.
The AABB guidelines for transfusing erythrocytes 
containing sickle haemoglobin recommend avoiding 
transfusion of HbAS blood to foetuses and neonates, 
as well as to patients with sickle cell disease, but 
there is no deÞ nitive clinical evidence indicating a 
necessity to exclude RBC units containing HbAS 
for general transfusion5. Despite the fact that RBC 
containing HbAS are diluted in the recipient upon 
transfusion, under anoxic conditions that may 
exist in the recipient's capillaries, these RBC may 
become rigid due to gelation of HbAS resulting 
in compromised oxygen delivery. Furthermore, 
RBC sickling in anoxic capillaries may result in 
capillary plugging and further harm the tissues. The 
safety of HbAS blood in the context of the general 
blood supply is an issue that lies outside the scope 
of Dr. Ahmed's letter. For the reasons stated above 
however, we believe it is one that merits further 
careful scrutiny.
In routine transfusion practice, we do not expect 
any harm to come from transfusing anaerobic blood to 
recipients, since infused RBC will be fully oxygenated 
at their Þ rst pass through the pulmonary capillaries. 
The effects of transfusing anaerobic blood to sickle cell 
disease patients will also need careful investigation.
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